Philogen S.p.a.
Clinical trials sponsored by Philogen S.p.a., explained in plain language.
-
New shot before surgery may keep melanoma from coming back
Disease control Recruiting nowThis study tests whether injecting a drug called Daromun into melanoma tumors before surgery can help keep the cancer from returning. About 186 people with stage IIIB, IIIC, or IIID melanoma will either get Daromun plus standard surgery and follow-up treatment, or just surgery an…
Phase: PHASE3 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated May 26, 2026 04:59 UTC
-
New drug combo targets tough tumors in early trial
Disease control Recruiting nowThis early-phase study tests a new drug, [177Lu]Lu-OncoFAP-23, alone or with another drug (L19-IL2), in people with advanced solid tumors that have a protein called FAP. The main goal is to check safety and find the best dose. About 56 adults whose cancer has worsened after stand…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated May 26, 2026 04:58 UTC
-
New drug targets Hard-to-Treat cancers after immunotherapy fails
Disease control Recruiting nowThis early-phase study tests a new drug called IL12-L19L19 in 80 adults with advanced or metastatic solid tumors that have not responded to standard immunotherapy. The main goal is to find a safe dose and check for early signs that the drug might shrink tumors. The drug is design…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New injection aims to ease arthritis pain in early trial
Symptom relief Recruiting nowThis early-stage study tests a new drug called F8IL10, given as an injection directly into the joint, for people with rheumatoid arthritis. The main goal is to check its safety and find the best dose. About 42 adults with active arthritis in a knee, ankle, shoulder, wrist, or elb…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Symptom relief
Last updated May 26, 2026 04:35 UTC